Pharmabiz18h
Sandoz announces European Commission grants marketing authorization for Pyzchiva
Sandoz, the global leader in generic and biosimilar medicines, announces that the European Commission (EC) has granted marketing authorization for Pyzchiva (biosimilar ustekinumab), developed and ...
Pharmabiz14h
Roche signs MoU with VinCense to augment access to diabetes care in Tamil Nadu
Roche signs MoU with VinCense to augment access to diabetes care in Tamil Nadu: Our Bureau, Mumbai Wednesday, April 24, 2024, 17:15 Hrs [IST] Roche announced that the company has ...
Pharmabiz9h
Zealand Pharma selects Benchling R&D Cloud as its central source of truth for scientific data, collaboration and insights
Benchling, a company creates the software that powers the biotechnology industry, announced that Zealand Pharma A/S, (Zealand) a biotechnology company focused on the discovery and development of ...
Pharmabiz19h
Sanofi’s LUNA 3 phase 3 study of rilzabrutinib in patients with immune thrombocytopenia meets primary endpoint
Sanofi’s LUNA 3 phase 3 study of rilzabrutinib in patients with immune thrombocytopenia meets primary endpoint: Paris Wednesday, April 24, 2024, 12:00 Hrs [IST] Positive results ...
Pharmabiz15h
Par Pharma recalls seven lots of Treprostinil injection due to potential for silicone particulates in the product solution
Par Pharma recalls seven lots of Treprostinil injection due to potential for silicone particulates in the product solution: Dublin Wednesday, April 24, 2024, 15:30 Hrs [IST] Endo ...
Pharmabiz12h
Lupin receives EIR from US FDA for its Aurangabad manufacturing facility
Global pharma major Lupin Limited (Lupin) announced that it has received the Establishment Inspection Report (EIR) from the United States Food and Drug Administration (FDA) for its Aurangabad ...
Pharmabiz16h
Vertex Pharma obtains exclusive license to TreeFrog's C-Stem to optimize production of its cell therapies for type 1 diabetes
Vertex Pharma obtains exclusive license to TreeFrog's C-Stem to optimize production of its cell therapies for type 1 diabetes: Boston Wednesday, April 24, 2024, 15:00 Hrs [IST] Ve ...
Pharmabiz17h
EU approves Voydeya as an add-on treatment to ravulizumab or eculizumab for adults with rare disease PNH who have residual haemolytic anaemia
EU approves Voydeya as an add-on treatment to ravulizumab or eculizumab for adults with rare disease PNH who have residual haemolytic anaemia: Cambridge, UK Wednesday, April 24, 2 ...
Pharmabiz22h
Pfizer’s Emblaveo receives European marketing approval for patients with multidrug-resistant infections and limited treatment options
Pfizer’s Emblaveo receives European marketing approval for patients with multidrug-resistant infections and limited treatment options: New York Wednesday, April 24, 2024, 09:00 ...
Pharmabiz21h
Lilly buys FDA-approved new injectable medicine manufacturing facility from Nexus Pharma
Lilly buys FDA-approved new injectable medicine manufacturing facility from Nexus Pharma: Indianapolis Wednesday, April 24, 2024, 10:00 Hrs [IST] Eli Lilly and Company and Nexus P ...
Pharmabiz8h
ZYUS Life Sciences receives US patent entitled ‘Formulation for Pain Management’
ZYUS Life Sciences Corporation, a Canadian-based life sciences company focused on the development and commercialization of novel cannabinoid-based pharmaceutical drug candidates for pain management, ...
Pharmabiz20h
Moderna enters contract with Brazil to supply 12.5 million Covid-19 vaccines as part of national vaccination campaign
Moderna enters contract with Brazil to supply 12.5 million Covid-19 vaccines as part of national vaccination campaign: Cambridge, Massachusetts Wednesday, April 24, 2024, 11:00 Hr ...